Biomarker development in the precision medicine era: lung cancer as a case study

被引：407
|
作者：
Vargas, Ashley J. [1 ,2 ]
Harris, Curtis C. [1 ]
机构：
[1] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Room 3068A,MSC 425,837 Convent Dr, Bethesda, MD 20892 USA
[2] NCI, Canc Prevent Div, Rockville, MD 20850 USA
来源：
NATURE REVIEWS CANCER | 2016年 / 16卷 / 08期
关键词：
C-REACTIVE PROTEIN; REPORTING RECOMMENDATIONS; GENE-EXPRESSION; INTERNATIONAL-ASSOCIATION; PROGNOSTIC CLASSIFIER; COMPANION DIAGNOSTICS; AFRICAN-AMERICANS; EGFR MUTATIONS; MESSENGER-RNA; NEVER SMOKERS;
D O I：
10.1038/nrc.2016.56
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable 'omics'-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is still stymied by low statistical power and poor reproducibility of results. This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the future of precision medicine research.
引用
收藏
页码：525 / 537
页数：13
相关论文
共 50 条
  • [21] Development of molecularly-stratified precision medicine in lung cancer
    Matsumoto, Shingo
    ANNALS OF ONCOLOGY, 2023, 34 : S1351 - S1351
  • [22] Integrative cancer genomics in the era of precision cancer medicine
    Johji Inazawa
    Yoshio Miki
    Yusuke Nakamura
    Journal of Human Genetics, 2021, 66 : 843 - 843
  • [23] Integrative cancer genomics in the era of precision cancer medicine
    Inazawa, Johji
    Miki, Yoshio
    Nakamura, Yusuke
    JOURNAL OF HUMAN GENETICS, 2021, 66 (09) : 843 - 843
  • [24] A case of constrictive pericarditis in the precision medicine era
    Angeli, Francesco
    Bartoli, Lorenzo
    Chiti, Chiara
    Fabrizio, Michele
    Stefanizzi, Andrea
    Paolisso, Pasquale
    Donati, Francesco
    Toniolo, Sebastiano
    Bergamaschi, Luca
    Rinaldi, Andrea
    D'Angelo, Emanuela Concetta
    Magnani, Ilenia
    Foa, Alberto
    Pizzi, Carmine
    Galie, Nazzareno
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N127 - N127
  • [25] Characterization of URST1 as a biomarker and therapeutic target for precision medicine of lung cancer
    Takano, Atsushi
    Miyagi, Yohei
    Daigo, Yataro
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Breast cancer screening in the precision medicine era
    Thompson, C. K.
    Fiscalini, A. S.
    Donnellan, P.
    Kaplan, C. P.
    Madlensky, L.
    Eklund, M.
    Ziv, E.
    van't Veer, L. J.
    Tice, J. A.
    Esserman, L. J.
    CANCER RESEARCH, 2016, 76
  • [27] Editorial: Cancer genomics in the era of precision medicine
    Khan, Omar M.
    Mallardo, Domenico
    Decock, Julie
    FRONTIERS IN GENETICS, 2024, 15
  • [28] Orphan Cancer Drugs in the Era of Precision Medicine
    Nabhan, Chadi
    Phillips, Eli G., Jr.
    Feinberg, Bruce A.
    JAMA ONCOLOGY, 2018, 4 (11) : 1481 - 1482
  • [29] Gastrointestinal cancer research in the era of precision medicine
    Lin Shen
    OncologyandTranslationalMedicine, 2017, 3 (01) : 1 - 2
  • [30] Personalised cancer care in the era of precision medicine
    Koczwara, Bogda
    Thornton-Benko, Elysia
    Cohn, Richard J.
    Chan, Raymond J.
    Rhee, Joel
    Joske, David
    Iddawela, Mahesh
    Vardy, Janette L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (08) : 533 - 537
12345